Discovery of high-affinity protein binding ligands--backwards

Area of Science:

• Biochemistry
• Molecular Biology
• Proteomics

Background:

• Developing high-affinity protein binding ligands is crucial for understanding biological systems.
• Current ligand development methods are often iterative and difficult to scale for large numbers of protein targets.

Purpose of the Study:

• To develop a novel, scalable method for generating high-affinity protein binding ligands.
• To create a new class of peptide-based ligands called synbodies for efficient target identification.

Main Methods:

• Developed synbodies, peptide-based ligands designed for reverse screening.
• Screened a synbody against a library of 8,000 human proteins to identify high-affinity binders.
• Characterized the binding affinity and specificity of synbody-protein interactions.

Main Results:

• Successfully generated a high-affinity synbody that specifically binds AKT1 with a dissociation constant (Kd) < 5 nM.
• Demonstrated that the bivalent interaction of synbody peptides enhances affinity and specificity.
• Developed a synbody for ABL1 using the same methodology.

Conclusions:

• The synbody approach enables high-affinity ligand discovery in a single step, surpassing iterative methods.
• This scalable technique holds potential for developing ligands against all proteins within a proteome.
• Synbodies offer a promising platform for rapid and efficient generation of protein-specific ligands.